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Abstract
Tetracyclines are broad- spectrum antibiotics used to prevent or treat a variety of bacterial infections. Resistance is often 
mediated through mobile resistance genes, which encode one of the three main mechanisms: active efflux, ribosomal target 
protection or enzymatic degradation. In the last few decades, a large number of new tetracycline- resistance genes have been 
discovered in clinical settings. These genes are hypothesized to originate from environmental and commensal bacteria, but the 
diversity of tetracycline- resistance determinants that have not yet been mobilized into pathogens is unknown. In this study, we 
aimed to characterize the potential tetracycline resistome by screening genomic and metagenomic data for novel resistance 
genes. By using probabilistic models, we predicted 1254 unique putative tetracycline resistance genes, representing 195 gene 
families (<70 % amino acid sequence identity), whereof 164 families had not been described previously. Out of 17 predicted 
genes selected for experimental verification, 7 induced a resistance phenotype in an Escherichia coli host. Several of the pre-
dicted genes were located on mobile genetic elements or in regions that indicated mobility, suggesting that they easily can be 
shared between bacteria. Furthermore, phylogenetic analysis indicated several events of horizontal gene transfer between 
bacterial phyla. Our results also suggested that acquired efflux pumps originate from proteobacterial species, while riboso-
mal protection genes have been mobilized from Firmicutes and Actinobacteria. This study significantly expands the knowledge 
of known and putatively novel tetracycline resistance genes, their mobility and evolutionary history. The study also provides 
insights into the unknown resistome and genes that may be encountered in clinical settings in the future.
DATA SUMMARY
The data analysed in this study consisted of pre- existing 
datasets, which are specified in Table 1 and throughout the 
text. The genes used to construct the hidden Markov models 
are listed in Table S1 (available with the online version of 
this article). The new genes predicted in this work are listed 
in Table S3, together with their respective protein sequences. 
The fARGene method is publicly available at https:// github. 
com/ fannyhb/ fargene.
INTRODUCTION
Tetracyclines are broad- spectrum antibiotics widely used to 
treat a broad range of bacterial infections since their discovery 
and introduction as clinical agents in the 1940s. Efficiency 
against many forms of both Gram- negative and Gram- 
positive bacteria in combination with relatively few side 
effects have made tetracyclines one of the most extensively 
used classes of antibiotics, and the most used class for animals 
[1]. In addition to clinical use, tetracyclines are commonly 
used in subtherapeutic doses to induce growth- promotion in, 
for example, swine and poultry [2]. Together, this has resulted 
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significantly reducing the value of tetracyclines as antibiotics 
[1, 3]. Increasing resistance has spawned the development 
of synthetically modified tetracyclines, such as minocycline, 
doxycycline and tigecycline; however, new forms of resistance 
encompassing the newer tetracyclines continue to emerge and 
spread [4].
Tetracycline resistance is often based on three main biochem-
ical mechanisms, alone or in combination: (i) active export 
of the tetracycline molecules via efflux pumps, (ii) weakening 
of the interaction between tetracycline and the ribosome 
(ribosomal protection), and (iii) enzymatic degradation of 
tetracycline via hydroxylation [1, 4, 5]. Tetracycline resistance 
genes encoding these mechanisms are often encountered on 
mobile genetic elements, which makes them easily transfer-
rable between bacteria. Indeed, the number of discovered and 
confirmed tetracycline resistance genes has increased dramat-
ically over the last few decades, mainly due to horizontal gene 
transfer between bacteria [1]. To date, 62 different tetracycline 
resistance gene families have been discovered (<80 % amino 
acid sequence identity), where 35 encode efflux proteins, 13 
encode ribosomal protection proteins and 14 encode inacti-
vating enzymes [6].
Many antibiotic- resistance genes (ARGs) frequently encoun-
tered in clinical isolates are hypothesized not to originate 
from pathogenic bacteria. In fact, environmental and 
commensal bacteria maintain large and diverse resistomes 
from which ARGs can be mobilized into pathogens [7, 8]. 
A recent example is the gene tet(X), which was discovered 
in the 1980s and whose product catalyses the degradation of 
tetracyclines, including tigecycline [9–11]. During the last 
decade, tet(X) has been detected in a wide range of human 
pathogens, including Klebsiella pneumoniae and members 
of Pseudomonadaceae, and today constitutes an increasing 
clinical problem [12, 13]. The gene was first discovered on a 
transposable element in Bacteroides fragilis, a strict anaerobe, 
and given that tet(X) is dependent on oxygen, it has been 
suggested that this is not its original host [14]. Another 
example is the ribosomal protection gene otr(A), which has 
been found in Streptomyces spp. and Mycobacterium spp., but 
is expected to have an environmental origin [4]. This suggests 
that environmental bacteria harbour a collection – a reservoir 
– of tetracycline resistance genes that can be transferred into 
human pathogens over time [15]. The size and diversity of 
the tetracycline resistome are, however, unclear; therefore, we 
do not know which resistance genes may be transferred into 
pathogens in the future. Knowledge about the future forms 
of tetracycline resistance genes may enable early diagnostics 
and facilitate the implementation of management strategies 
to limit the spread of new forms of multiresistant bacteria.
Functional metagenomics – a method where random pieces of 
DNA from microbial communities are extracted and inserted 
into a bacterial host that is tested for induced phenotypes – is 
widely used to identify novel ARGs [16–18]. Analysis of soil 
using functional metagenomics was, for example, used to 
identify nine new genes for enzymatic degradation of tetracy-
cline [tet(47)–tet(55)] [5]. Although functional metagenomics 
enables detection of novel ARGs without any prior knowledge 
about previously described genes, the method has a relatively 
low throughput (typically, ~10 Gb DNA is incorporated per 
experiment), which makes it unsuitable for characterization 
of novel ARGs at a larger scale. An alternative approach is to 
search for novel ARGs in genomic and shotgun metagenomic 
data. The great majority of newly discovered ARGs are evolu-
tionarily related to resistance genes that are already known, 
allowing patterns of previously uncharacterized ARGs to be 
identified through sequence analysis. We have previously 
developed fARGene, a highly sensitive computational method 
based on hidden Markov models, for this particular purpose 
[19, 20]. By screening large volumes of genomic and metagen-
omic data we were able, for example, to significantly expand 
the number of subclass B1 metallo-β-lactamases, from 22 to 
81 gene families [21]. Given the rapidly increasing volumes 
of bacterial genomic data present in public repositories, this 
approach has the potential to explore the diversity of novel 
ARGs in the bacterial communities at a much larger scale.
In this study, we aimed to expand the number of characterized 
tetracycline resistance genes and thereby provide a clearer 
picture of their evolutionary histories and origins. Through 
large- scale screening of genomic and metagenomic data using 
highly sensitive and optimized probabilistic gene models, 
we predicted 195 families of putative tetracycline resistance 
genes, of which 164 were novel and, thus, previously unchar-
acterized. Seventeen of the predicted genes were synthetically 
constructed and expressed in Escherichia coli, whereof seven 
resulted in an induced resistance phenotype. Phylogenetic 
analysis identified several horizontal gene transfer events 
Impact Statement
Tetracyclines are one of the most widely used classes of 
antibiotics and crucial for treating many forms of infec-
tion. However, the incidence of tetracycline resistant 
bacteria is increasing globally, which is to a large extent 
caused by new variants of tetracycline- resistance genes 
encountered in pathogens. These genes are hypothesized 
to originate from an unexplored reservoir of tetracycline 
resistance genes maintained by environmental bacteria. 
The size and content of this reservoir are unknown and, 
thus, we do not know the evolutionary history of the 
known tetracycline resistance genes and which novel 
genes we may encounter in the future. In this study, 
we have characterized a large number of new putative 
tetracycline resistance genes not yet encountered in 
clinical settings. Phylogenetic analysis of the predicted 
and previously known tetracycline resistance genes 
has given new insights about their evolutionary origin 
and mobility patterns. This study significantly expands 
the known tetracycline resistome, and describes which 
resistance genes may be mobilized and transferred into 
pathogens in the future.
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between phyla. Our results are indicative that mobile efflux 
pumps were mobilized from Proteobacteria, while mobile 
ribosomal protection genes were mobilized from Firmicutes 
and/or Actinobacteria. The study presented here significantly 
expands the potential tetracycline resistome, and increases 
our knowledge about the diversity and evolutionary history 
of the tetracycline resistance genes.
METHODS
Gene prediction using fARGene
The genes presented in this study were predicted using 
the recently developed computation method fARGene, 
which can reconstruct both known and novel genes from 
fragmented metagenomic data [19]. Briefly, the method 
starts by analysing raw reads using hmmer v.3.1b2 [22] 
and a hidden Markov model optimized for fragmented 
data. The reads classified as belonging to the gene class 
of interest are retrieved together with their read- pair and 
their quality is controlled using Trim Galore! v. 0.4.3 and 
a Phred score threshold of 30 [23]. The quality- controlled 
reads are assembled using SPAdes meta [24] and the assem-
bled contigs then proceed to a second classification step 
where the threshold score is optimized for full- length genes. 
The contigs in which a gene of interest is predicted are 
retrieved and searched for ORFs using the National Center 
for Biotechnology Information (NCBI) ORFfinder (stand- 
alone version) [25]. The predicted ORFs are analysed with 
the model once again, in order to retrieve the ORFs with the 
highest score, and then passed as nucleotide and amino acid 
Table 1. Predicted tetracycline resistance genes










2.78×1010 137 16/29 232 51/57 20 9/11
NCBI plasmids 
[77]
1.07×109 54 2/13 35 3/7 3 0/1




1.09×1011 23 7/15 317 17/23 17 3/6
HMP genomic 
[41]
6.83×109 20 2/8 105 7/12 4 1/3
Metagenomic
Human gut [47] 2.80×1011 3 0/2 13 0/5 2 0/2
HMP 
metagenome [45]
3.51×1012 3 0/3 10 3/5 2 0/2
Pig gut [44] 1.74×1012 9 0/7 13 6/10 1 0/1
WWTPs [42] 4.82×1011 11 4/8 14 5/12 3 2/3
Pune river [43] 3.93×1011 5 1/5 19 8/13 1 0/1
Polluted lake [50] 6.76×109 0 0 0 0 0 0
Polluted river 
[46]
2.86×1010 3 0/2 2 1/2 1 0/1
Oil spill [49] 3.39×1011 0 0 0 0 0 0
Tara Ocean [48] 4.89×1012 4 2/3 0 0 4 2/3
Well water [51] 7.62×1010 0 0 0 0 0 0
Soil [51] 5.05×1010 0 0 0 0 0 0
Total‡ 1.21×1013 331 38/53 927 106/116 96 20/26
*Non- redundant genes.
†Amino acid sequence identity cut- off of 70 %.
‡Non redundant genes/gene families.
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sequences as the final output. In addition to the metagen-
omic data, the method was also used to analyse genomic 
data, in which the assembly step is skipped and ORFs are 
predicted with Prodigal v2.6.3 [26] around the region where 
the gene of interest is identified. For full details, see our 
previous work [19].
Model creation and optimization
For this study, three hidden Markov models were used. Each 
was built to represent a tetracycline resistance mechanism: 
efflux pumps of major facilitator superfamily (MFS) group 
1, ribosomal protection and enzymatic degradation. Note 
that efflux pumps of other groups were not included in the 
study due to the limited number of known genes. The sensi-
tivity for each model was optimized using leave- one- out 
cross- validation, while the specificity was optimized by 
applying the model to a set of closely related sequences 
that lacked the desired phenotype. The efflux model was 
built using 18 proteins belonging to the tetracycline efflux 
group 1 [1, 4, 6]. The specificity of the model was estimated 
using 192 proteins from the MFS [27, 28]. The ribosomal 
protection gene model was built of 11 confirmed tetracy-
cline resistance ribosomal protection genes [6]. To estimate 
the specificity, 143 proteins belonging to conserved domain 
family elongation factor Tu GTP were used (PFAM00009). 
To build the enzyme model, all proteins verified as tetracy-
cline resistance enzymatic genes [6] were downloaded and 
used to recreate a phylogenetic tree using ete npr v. 0.9.32 
with parameters ‘-w standard_fasttree’ [29]. Based on the 
tree, the two genes tet(37) and tet(34) were removed due to 
their excessive diversion from the rest of the sequences. To 
enable the model to capture tet(X)- like genes, two variants 
of tet(X) were included in the model [tet(X) and tetX3]. As 
a negative dataset, 109 genes belonging to the conserved 
protein domain family UbiH (COG0654) were used. For a 
full list of genes used to build the three models see Table 
S1. The threshold scores for a fragment to be classified as 
positive were set based on manual inspection of the evalua-
tion results, focusing on as high sensitivity as possible while 
still maintaining the highest possible specificity, with a 
minimum limit of 0.9. For full- length genes, the threshold 
scores were set so that both sensitivity and specificity were 
one for all models except for efflux pumps. For the efflux 
pumps, the gene tet(42) had a significantly lower score 
compared to the other genes in the cross- validation, and 
the resulting threshold was set so that all efflux pump genes 
except tet(42) would be captured by the model, resulting in 
a sensitivity of 0.94. The resulting sensitivity and specificity 
for the three models can be seen in Table S2.
Post-processing and phylogenetic analysis
The predicted genes were grouped based on their resistance 
mechanisms and then clustered at 100 % sequence identity 
using usearch v. 8.0.1445 [30], parameters ‘-cluster- fast 
-id 1’, to remove redundant genes. Then, the genes were 
clustered together with all previously known tetracycline 
resistance genes with the same resistance mechanism with 
a 70 % amino acid sequence identity using usearch with 
parameters ‘-cluster- fast -id 0.7’. The 70 % sequence iden-
tity cut- off was chosen to ensure that previously known 
genes clustered consistently and, thus, that no gene family 
would incorrectly be annotated as new. The clusters that 
did not contain any previously known gene were called 
‘novel family’ (NF) and the number of genes clustering 
in any of the novel families were counted as well as the 
number of families. The generated centroid files from the 
clustering were then aligned using mafft v. 7.273 [31] and 
phylogenetic trees were recreated using FastTree v. 2.1.10 
with default settings [32]. To perform the phylum analysis, 
the bacterial species of each genome from NCBI RefSeq 
and Human Microbiome Project (HMP) genomic databases 
carrying at least one tetracycline resistance gene were 
extracted and counted. Duplicated species were removed 
and those remaining were organized into groups based 
on their phyla. The number of unique species in a phylum 
carrying a tetracycline resistance gene was then compared 
to the total number of unique species in this phylum in the 
original dataset using Fisher’s exact test.
Genetic context analysis
All genomes available in the GenBank assembly database, 
as well as all GenBank plasmid sequences (downloaded 
January 2019) were searched for the novel gene family 
amino acid sequences using diamond v0.9.24.125 blastx 
with an identity cut- off of 70 % [33]. For every hit, up to 
20 kb upstream and downstream were extracted and anno-
tated using prokka v1.12 [34]. Sequences annotated as 
hypothetical proteins were searched against the UniprotKB 
database using diamond blastx with a 50 % identity cut- off 
to investigate their potential function. The genetic environ-
ments of selected genes were further searched for mobile 
genetic elements using ISFinder and CDD search [35, 36].
Experimental validation
Potential tetracycline resistance genes were synthesized by 
Thermo Fisher Scientific, using the GeneArt gene synthesis 
service and provided in the vector pMK. Each candidate 
gene sequence was equipped with the promoter Pbla plus 
ribosomal binding site upstream and the rrnB terminator 
T1 downstream to ensure constitutive expression. The nega-
tive control consisted of the expression elements without 
any gene, the positive controls were tet(X) [37] and tet(A) 
[38]. The pMK plasmids containing the resistance gene 
candidates were used to transform chemically competent 
E. coli TOP10 (Invitrogen, Thermo Fisher Scientific). 
The functionality of candidate genes was verified against 
both tetracycline (Sigma Aldrich, Merck) and tigecycline 
(Glentham Life Sciences). Minimum inhibitory concentra-
tions (MICs) were determined by broth microdilution in 
cation- adjusted Mueller- Hinton medium. In accordance 
with European Committee on Antimicrobial Susceptibility 
Testing (EUCAST) guidelines (clinical breakpoint tables v. 
9.0), medium for tigecycline tests was prepared freshly on 
the day of use. Serial dilutions of the tested antibiotics were 
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prepared in triplicate in 96- well plates and inoculated with 
5×105 cells ml−1 in each well [39] at a final volume of 200 µl. 
After 24 h incubation at 37 °C and 180 r.p.m., optical density 
(OD650) was measured (Spectramax 340PC 384; Molecular 
Devices) and the MIC was defined as the lowest concentra-
tion of an antimicrobial that reduced growth to an OD650 
≤0.2 [40].
Growth behaviour of selected constructs was determined 
at different tetracycline concentrations using the OmniLog 
system (Biolog). Bacteria were grown in 96- well plates as 
described above with the addition of redox dye A. During 
24 h incubation at 37 °C, metabolic activity was measured 
every 15 min in the form of a colour change caused by the 
reduction of the dye (OmniLog units). Growth curves and 
standard deviations were calculated from the mean of three 
independent experiments, each consisting of three technical 
replicates. The reported P values were calculated using a 
one- sided two- sample t- test with the values taken from the 
24th hour of incubation at a tetracycline concentration of 
0.45 µg ml−1. Since the current nomenclature of tetracycline 
resistance genes requires that the putative gene should 
be shown to be functional in its original host, none of the 
experimentally verified genes could be given an official name.
RESULTS
Creation and evaluation of tetracycline resistance 
gene models
Genomic and metagenomic data were analysed for tetracy-
cline resistance genes (both known and new) using fARGene, 
a computational method that applies probabilistic gene 
models to find ARGs (see our previously published work 
[19]). Three gene models were developed, corresponding to 
each of the three major mechanisms of tetracycline resistance: 
the MFS efflux pumps of type group 1, ribosomal protection 
genes and enzymatic degradation genes [1]. The models were 
trained using previously known tetracycline resistance genes, 
and the sensitivity and specificity were optimized for both 
short reads and full- length genes using cross- validation. 
The resulting models all had a specificity of 1 for full- length 
genes, while the full- length sensitivity was 1 for all but the 
efflux pump model, which had a sensitivity of 0.94. The 
specificity for fragments (100 nucleotides) was at least 0.90 
for all models (0.93, 0.90 and 0.97 for enzymatic, ribosomal 
protection and efflux pump genes, respectively), while the 
sensitivity ranged from 0.78 (ribosomal protection genes) 
to 0.96 (enzymatic degradation genes) (see Methods and 
Table S2 for more details). Using the gene models, fARGene 
was applied to more than 12 Tb of genomic and fragmented 
metagenomic data. This resulted in 1354 unique predicted 
tetracycline resistance genes, which were clustered into 195 
gene families, of which 164 families were novel (amino acid 
sequence identity <70 % to any previously known tetracy-
cline resistance gene) (Tables 1 and S3). Genes encoding 
ribosomal protection genes were most common (927 genes 
in 116 families, of which 106 were novel), followed by efflux 
genes (331 genes in 53 families, of which 38 were novel) and 
enzymatic degradation genes (96 genes in 26 families, of 
which 20 were novel).
Prediction of tetracycline-resistance genes in 
genome sequence data
The genomic data (NCBI genome, NCBI plasmids, NCBI nt, 
NCBI environmental, HMP genomic [41]) yielded a predic-
tion of 1278 unique tetracycline resistance genes (Table 1). 
Among the 7376 complete genomes present in the NCBI 
genome database, 542 (7.3 %) carried at least one predicted 
tetracycline- resistance gene, whereof 51 (0.7 %) and 3 
(0.04 %) carried two and three genes, respectively. Ribo-
somal protection genes were most commonly predicted (314 
genomes, 4.3 %), followed by efflux pumps (244 genomes, 
3.3 %) and degradation enzymes (32 genomes, 0.4 %). In 
addition, 458 (4.0 %) plasmids present in the NCBI plasmids 
database carried at least one predicted tetracycline resist-
ance gene (Table 1). Enrichment analysis, where the observed 
proportion of predicted resistant species in each phylum in 
NCBI genome (7376 genomes) and HMP genomic (1271 
genomes) was compared to what was expected by chance, 
showed that the distribution of tetracycline- resistance genes 
was associated with taxonomy (see Methods). In particular, 
Proteobacteria were underrepresented carriers of both 
ribosomal protection genes (ratio 0.09 with P <10−15) and 
enzymatic degradation genes (ratio 0.06, P=1.4×10−4), while 
efflux pump genes were overrepresented (ratio 6.74, P <10−15) 
(Fig. 1). In contrast, Firmicutes showed an overrepresenta-
tion of ribosomal protection genes (ratio 3.86, P <10−15), 
while Bacteroidetes showed an overrepresentation of both 
ribosomal protection and enzymatic degradation genes (ratio 
2.99, P=5.8×10−11, and ratio 8.31, P=9.0×10−6, respectively). 
Finally, Actinobacteria showed an overrepresentation of 
ribosomal protection genes and an underrepresentation of 
efflux pump genes (ratio 2.08, P=5.3×10−7, and ratio 0.27, 
P=2.3×10−4, respectively).
Fig. 1. Phylum analysis of genomes carrying tetracycline resistance 
genes. The analysis was based on genomes present in NCBI RefSeq and 
HMP genomic databases. The significance of the ratios was assessed 
using Fisher’s exact test and results with P <0.001 are marked by 
asterisks. RPG, Ribosomal protection genes.
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Prediction of tetracycline resistance genes in 
metagenomic data
From the metagenomic data, which consisted of human and 
animal- related sources, as well as samples from polluted and 
more pristine environments (Table  1), 98 non- redundant 
genes (123 genes in total) were predicted. Similar to the 
genomic data, ribosomal protection genes were the most 
common (61 unique genes corresponding to 24 families, of 
which 17 were novel), followed by efflux pumps (28 genes in 
16 families, of which 7 were novel) and enzymatic degradation 
genes (9 genes in 8 families, of which 5 were novel) (Fig. 2). 
This corresponded to 0.006, 0.0024 and 0.0012 reconstructed 
genes Gb−1 for ribosomal protection genes, efflux pumps and 
degradation enzymes, respectively. Putative tetracycline 
resistance genes were found in all but four of the metagenomic 
datasets, but their abundance varied considerably between 
communities. The highest number of genes was found in the 
metagenomes from Swedish wastewater treatment plants 
(WWTPs) [42], sediments from Pune river (Pune, India) 
[43] and in pig microbiome (pig gut) [44]. Furthermore, the 
wastewater treatment plant metagenome was the only dataset 
that contained novel genes of all three resistance mechanisms. 
Efflux pump genes were especially abundant in wastewater 
treatment plants and the pig microbiome.
Ribosomal protection genes were only found in the human 
and animal- related datasets together with sediments from two 
polluted rivers (human gut, HMP metagenome, WWTPs, pig 
gut, Pune river and polluted river (Isakavagu, India)) [45–47]. 
Compared to efflux pump genes and enzymatic degradation 
genes, ribosomal protection genes were highly abundant in 
the human and pig microbiomes. Furthermore, only 4 out of 
23 (17 %) ribosomal protections genes found in the human 
microbiome (human gut and HMP metagenome) were novel. 
The human gut metagenome (human gut) only contained 
previously known genes, while the HMP metagenome did 
neither contain any novel enzymatic nor novel efflux pump 
genes. Enzymatic degradation genes were rare overall, but had 
the largest proportion of novel genes (5 out of 9, 56 %), which 
were all found in the wastewater treatment plant and marine 
environment (WWTPs and Tara Ocean [48]) metagenomes. 
The previously known tetracycline resistance genes found in 
the most environments were tet(A) (efflux), tetB(P) (ribo-
somal) and tet(X) (enzymatic), which all were found in five 
environments, respectively (Table S4). Finally, the analysis of 
data from oil- contaminated deep- sea water (oil spill) [49], the 
Kazipally lake in India polluted with wastewater from phar-
maceutical manufacturing (polluted lake) [50], and bacterial 
communities in Indian soil and well water [51] did not yield 
any reconstructed full- length tetracycline resistance genes.
Experimental verification
Next, we investigated whether some of the predicted genes 
induced a resistance phenotype in E. coli. In total, 17 
predicted novel genes – 5 enzymatic degradation genes, 6 
ribosomal protection genes and 6 efflux genes – were chosen 
from different parts of their respective phylogenetic tree. 
The genes were synthesized and inserted into an E. coli host, 
after which the MIC was determined (Table 2, Methods). For 
three genes, the growth rate in the presence of tetracycline was 
also measured (G231 in NF54 and G242 in NF55 ribosomal 
protection; G241 in NF21 efflux). For seven of the tested 
genes, expression in E. coli resulted in a resistance pheno-
type (Table 2). The highest increase in MIC was >256- fold 
and was observed for the efflux gene G256 in NF26. MIC 
assays were inconclusive for two of the ribosomal protec-
tion genes (increase in MIC between 1 and 4), but a more 
detailed analysis of growth rate over time showed that both 
genes increased growth significantly compared to the control 
(Fig. S1). Ten genes did not induce a resistance phenotype in 
E. coli (Table  2). Non- functionality in the tested host is, 
however, not evidence for lack of resistance function, as the 
genes may be functional in their native context and species 
Fig. 2. Number of reconstructed genes Gb−1 for each metagenomic dataset. A reconstructed gene was classified as novel if it had a 
sequence identity of <70 % to any previously known tetracycline resistance gene. RPG, Ribosomal protection genes.
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more closely related to their actual hosts. Even in E. coli, 
the resulting MIC for a given ARG can be highly strain- 
dependent [52]; hence, we put more emphasis on increases 
in MICs rather than on the absolute MIC values.
Phylogenetic analysis
Next, all predicted tetracycline resistance genes (1354 unique 
genes, corresponding to 195 families) were used to recreate 
three phylogenetic trees, one for each resistance mechanism 
(see Methods). The phylogenetic tree of the enzymatic degra-
dation genes, consisting of 26 gene families (Figs 3 and S2), 
was separated into two monophyletic groups. The first group 
consisted of the known tet(X), a full- length variant of the 
tet(X) homologue tetX1 [53] and a novel gene family (NF20). 
In addition to the predicted novel genes, we investigated 
whether the full- length variant of tetX1 induced a resistance 
phenotype in E. coli. However, similar to previous reports on 
the truncated variant of tetX1, we did not see any increase in 
MIC against either tetracycline or tigecycline for either NF20 
(G47) or the full- length tetX1 variant [10]. The second group 
contained all other previously known enzymatic degradation 
genes [tet(47) to tet(55)] and was more diverse, with genes 
from five phyla and a wide range of metagenomic datasets 
(Fig. 3). Interestingly, the clade where tet(47) to tet(55) were 
located contained only two genes found in genomes, which 
were both pathogens: the proteobacterial species Legionella 
lansingensis and the Chlamydiae species Simkania negevensis 
[54, 55].
The phylogenetic analysis of the ribosomal protection genes 
was based on a total of 116 gene families (Figs 4 and S3). 
Similarly to the enzymatic degradation genes, the tree could 
be divided into two major groups. The first group contained 
all previously known ribosomal protection genes except for 
Table 2. Summary of the functional verification in E. coli of 17 predicted genes




Species Most similar 
previously 
known
Amino acid identity to most 
similar known (%)
Enzyme G8 NF3 – nd Labilithrix luteola tet(55) 40.3
Enzyme G35 NF11 – nd Bacillus simplex tet(55) 39.7
Enzyme G38 NF13 – nd Legionella lansingensis tet(49) 41.5
Enzyme G42 NF17 128 nd Metagenome tet(47) 54.0
Enzyme G47 NF20 – nd Niabella ginsenosidivorans tet(X) 63.9
Ribosomal 
protection
G139 NF28 – nd Jiangella alkaliphila otr(A) 52.0
Ribosomal 
protection
G161 NF35 – nd Cloacibacillus porcorum tetB(P) 34.7
Ribosomal 
protection
G231 NF54 1–4 p=1.6×10−4 Ensifer adhaerens (P)† otr(A) 44.5
Ribosomal 
protection
G242 NF55 1–4 p=5.8×10−3 Pseudomonas chlororaphis otr(A) 43.9
Ribosomal 
protection





G404 NF81 – nd Rhizobium sp. LPU83 (P)† otr(A) 44.7
Efflux G131 NF12 – nd Burkholderia sp. 
PAMC26561 (P)†
tet(A) 49.7
Efflux G160 NF17 – nd Ensifer adhaerens (P)† tet(41) 50.7
Efflux G241 NF21 – p=0.26 Acinetobacter baumannii tet(41) 44.6
Efflux G256 NF26 256–512 nd Uncultured bacterium tet(G) 62.8
Efflux G281 NF34 128–256 nd Ochrobactrum anthropi tet(G) 55.3




*P values calculated at hour 24 with a tetracycline concentration of 0.45 µg ml−1.
†Plasmid.
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otr(A). The first group could be further separated into two 
distinct clades. Clade one in group one contained all of the 
previously known genes together with genes reconstructed 
from the bacterial communities from river sediment (Pune 
river) and wastewater treatment plants (WWTPs). The second 
clade in group one contained only novel genes, of which several 
were found in the pig gut metagenome. Relatively few of the 
genes in the first group were identified in genomic data, and 
this could not be associated with any host. However, two gene 
families that were the closest related to the previously known 
genes were both found in Firmicutes species: NF60, identified 
in Clostridium saccharolyticum and the pathogen Clostridium 
sphenoides [56]; and NF98, identified in Lanchospiraceae sp. 
The NF60 gene variant G307 in Clostridium saccharolyticum 
was functional when expressed in E. coli. Genes from NF60 
were also commonly detected in metagenomes from both the 
environment and the human microbiome, suggesting that 
these genes are widely spread. Furthermore, several species 
from Paenibacillus – a genus responsible for the American 
foulbrood disease in honeybees and commonly treated with 
tetracycline – carried predicted novel families of ribosomal 
protection genes [57]. The second group of the phyloge-
netic tree contained the known otr(A) gene, which was first 
discovered in an oxytetracycline- producing Streptomyces spp. 
[4, 58, 59]. This part of the tree consisted mainly of genes 
located in other Actinobacteria (56 novel families). A small 
clade within the second group with novel gene families from 
proteobacterial species contained two genes located on plas-
mids (G232 in NF54, Ensifer adhaerens, and G404 in NF81, 
Rhizobium sp. LPU83) indicative of horizontal gene transfer 
across bacterial phyla. In the same clade, another resistance 
gene was present in Pseudomonas chlororaphis. This species 
is root- colonizing and has previously been shown to promote 
plant growth and to have biopesticide properties [60]. When 
expressed in E. coli, the gene located on the plasmid in Ensifer 
adhaerens and the one located in Pseudomonas chlororaphis 
did not result in an increased MIC, but both showed signifi-
cantly increased growth rates in the presence of tetracycline 
compared to the negative control (Table 2, Fig. S1).
The phylogenetic tree of the efflux pump genes consisted 
mainly of genes found in genomic data. Most genes appeared 
in Proteobacteria, but some were also found in species of 
Acidobacteria, Actinobacteria, Planctomycetes and Deino-
coccus–Thermus (Figs 5 and S4). The known efflux pump genes 
were distributed over the entire tree, but several accumulated 
in a clade containing novel genes from Alphaproteobacteria 
and Betaproteobacteria (including the pathogens Ochro-
bactrum anthropi and Achromobacter spp.). Furthermore, 
we identified two novel families (NF12, NF17) with genes 
located on plasmids. The plasmid carrying a variant of NF17 
was found in Ensifer adhaerens, but located on a different 
Fig. 3. Phylogenetic tree of the enzymatic tetracycline- resistance genes predicted in this study. The tree was recreated from all previously 
known enzymatic tetracycline- resistance gene families, together with gene families predicted in this study. Each gene family contains 
genes with >70 % amino acid sequence identity, and the number of unique genes in each gene family is presented within the square 
brackets. The gene functional in E. coli is indicated by an asterisk and the gene families for which the tested genes did not function in  
E. coli are indicated by hash signs. The scale bar indicates number of substitutions per site.
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plasmid separate from the ribosomal protection gene present 
in the same species. The gene family NF17 also contained 
genes from five additional genera of Alphaproteobacteria: 
Rhizobium, Janthinobacterium, Devosia, Agrobacterium and 
Neorhizobium. Finally, a plasmid harbouring NF12 was 
found in Burkholderia sp. PAMC 26561 (G131), while other 
members of the same gene family were found in Labilithrix 
luteola and the marine metagenome (Tara Ocean).
Fig. 4. Phylogenetic tree of the ribosomal protection genes predicted in this study. The tree was recreated from all previously known 
ribosomal protection gene families, together with gene families predicted in this study. Each gene family contains genes with >70 % 
amino acid sequence identity, and the number of unique genes in each family is presented within the square brackets. The gene families 
functional in E. coli are indicated by asterisks and the gene families for which the tested genes did not function in E. coli are indicated by 
hash signs. The scale bar indicates number of substitutions per site.
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DISCUSSION
In this study, we have presented a large- scale prediction of 
novel tetracycline resistance genes. This was performed by 
using sensitive probabilistic models developed to specifi-
cally identify novel tetracycline resistance genes, even when 
they have low sequence identity to known resistance genes 
[19]. Large amounts of genomic and metagenomic data were 
screened, and the predicted genes were used to infer their 
evolutionary history. Our study identified all previously 
known tetracycline resistance genes of the three modelled 
main mechanisms, together with 164 predicted novel gene 
families. These results expand the potential tetracycline 
resistome significantly. In addition, experimental validation 
of 17 predicted genes showed that 7 of these resulted in a 
resistance phenotype when expressed in E. coli, indicating 
that they are functional in this host.
The number of predicted genes differed considerably between 
the three main resistance mechanisms investigated in this 
study: efflux pump genes, ribosomal protection genes and 
enzyme degradation genes. Most common were ribosomal 
protection genes (927), followed by efflux pumps genes (331) 
and enzymatic degradation genes (96). Efflux pump genes 
were found in a larger number of phyla (nine), compared to 
six and five phyla for ribosomal protection genes and enzy-
matic degradation genes, respectively. There were also clear 
taxonomic differences between genes from the three resist-
ance mechanisms. Efflux pump genes were overrepresented in 
Proteobacteria with more than 8 % of the unique proteobacte-
rial species in HMP genomic and NCBI RefSeq carrying an 
efflux pump gene, while enzymatic degradation and ribosomal 
protection genes were underrepresented in Proteobacteria. 
These resistance mechanisms were more common in other 
phyla, in particular Bacteroidetes, and for ribosomal protec-
tion genes, also Actinobacteria and Firmicutes. In contrast, 
only three species of Bacteroidetes were carrying efflux pump 
genes. Note, however, that the enzymatic degradation genes 
Fig. 5. Phylogenetic tree of the efflux pump genes predicted in this study. The tree describes the previously known efflux gene families 
of MFS group 1, together with gene families predicted in this study. Each gene family contains genes with >70 % amino acid sequence 
identity, and the number of unique genes in each group is presented within the square brackets. The gene families functional in E. coli are 
indicated by asterisks and the gene families for which the tested genes did not function in E. coli are indicated by hash signs. The scale 
bar indicates number of substitutions per site.
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found in Bacteroidetes belonged to only four gene families, 
which included tet(X), tetX1 and novel family 20 that is closely 
related to tet(X) and tetX1. A similar pattern could be seen 
for the ribosomal protection genes, where all genes located in 
Bacteroidetes were either previously known or from a single 
novel family (NF31). Thus, even though enzymatic degrada-
tion genes and ribosomal protection genes were common in 
species from Bacteroidetes, these numbers represent mainly 
known mobile genes and, thus, only a limited part of the full 
diversity of these gene classes. However, it should be pointed 
out that the genomic data used in this study is likely biased 
towards well- studied organisms, in particular those related to 
human health; thus, the results are not representative of the 
full diversity of the tetracycline resistome.
The relative number of reconstructed tetracycline resistance 
genes varied between environments. The human and pig 
microbiomes, as well as environments that are potentially 
polluted by human faecal matter, all contained high levels of 
genes from all three resistance mechanisms. In these envi-
ronments, the enzymatic genes were heavily dominated by 
tet(X) and the previously studied tet(X)- like gene tetX1 [10, 
50]. A similar pattern was observed for ribosomal protec-
tion and efflux pumps genes, where the human microbiome 
contained almost exclusively previously known genes. Here, 
the abundance was especially high in the intestinal tract where 
Bacteroidetes is dominant [45], adding additional support to 
the hypothesis that bacteria from this phylum seem to carry a 
relatively limited set of mostly known tetracycline resistance 
genes. The environments that are likely to contain less faecal 
matter contained no tetracycline resistance genes at all, except 
for marine microbial communities in the Tara Ocean dataset, 
which contained both known and novel efflux pumps and 
enzymatic genes. An environment with a high abundance and 
diversity of novel resistance genes may indicate a higher risk 
for transfer events into recipients that will enable spread to 
pathogens. Based on our analysis, such environments include 
the human and animal- associated microbiomes, as well as the 
bacterial communities from the wastewater treatment plant 
(Table 1). Note, however, that aside from the Tara Ocean data, 
the environmental datasets used in this study were also the 
least deeply sequenced (especially the polluted lake dataset) 
and considering that the abundance needs to be fairly high 
for a gene to be reconstructed from a metagenomic dataset, 
it is likely that some resistance genes were below the limit of 
detection [61, 62]. Thus, we cannot exclude that there is a 
much larger diversity of novel tetracycline resistance genes 
in these communities than what is possible to detect with 
existing data.
The phylogenetic analysis showed the presence of potentially 
mobile novel tetracycline resistance genes. For example, the 
phylogenetic group containing the known ribosomal protec-
tion gene otr(A), which was dominated by Actinobacteria, 
contained a small clade of gene families from proteobacterial 
species (Fig. 4). One of these gene families (NF81) comprised 
a plasmid- borne gene from Rhizobium sp. LPU83 (G404), 
while another gene family (NF54) harboured a gene on a 
plasmid from Ensifer adhaerens (G231). Other members of 
this family are located in the genomes of Rhizobium sp. and 
Agrobacterium spp. None of these genes showed a consistent 
increase in MIC when expressed in E. coli. However, the 
gene located on the Ensifer adhaerens plasmid was tested 
in the growth assay and allowed significantly faster growth 
than the control, indicating that it is indeed functional. One 
additional gene family (NF55) from the same clade was found 
in Pseudomonas chlororaphis, and was also shown to induce 
a resistance phenotype in E. coli. The members of the genus 
Pseudomonas are known to have highly plastic genomes and 
to commonly harbour conjugative elements carrying ARGs 
[63]. Interestingly, the gene was located on a ~13 kb long 
insert present in three Pseudomonas chlororaphis strains, 
but absent in three other strains and all other Pseudomonas 
species. This insert also contained distant homologues to 
fosfomycin- resistance genes (33.6 % amino acid identity 
to FosA) and macrolides (34.9 % amino acid identity to 
OleC). Taken together, this indicates that there has been a 
horizontal gene transfer event of ribosomal protection genes 
from species within Actinobacteria to Proteobacteria. Since 
the genes are present on mobile genetic elements or, as in 
the case of Pseudomonas chlororaphis, highly plastic genomic 
regions, there is an apparent risk that they can spread further, 
including to human pathogens.
There were also indications of new mobile efflux pump genes. 
For example, two of the novel gene families had genes located 
on plasmids, one in Burkholderia sp. PAMC 26561 (G131 in 
NF12) and one in Ensifer adhaerens (G160 in NF17), although 
not the same strain as the one carrying a predicted ribosomal 
protection gene. Furthermore, genes within NF17 were found 
in the genomes of Janthinobacterium spp. and several species 
within the order Rhizobiales (Agrobacterium sp., Rhizobium 
spp., Devosia spp. and Neorhizobium sp.). Many of these 
species are symbiotic nitrogen- fixating bacteria associated 
with root nodules, and are known to often carry plasmids 
or megaplasmids harbouring genes essential for symbiosis 
with the host plant [64, 65]. Functional verification showed, 
however, that these genes did not result in an increased MIC 
when expressed in E. coli. Moreover, several of the predicted 
new efflux pump genes were located in opportunistic or 
pathogenic bacteria, e.g. Acinetobacter baumannii, Achromo-
bacter insolitus, O. anthropi, Pandoraea pulmonicola and Burk-
holderia cenocepacia [66–70]. Among these, Acinetobacter 
baumannii is a notorious pathogen harbouring a wide range 
of mobile resistance genes against clinically relevant antibi-
otics, including tetracyclines [71]. The gene family identified 
in Acinetobacter baumannii was only present in 25 of 155 
Acinetobacter baumannii strains in NCBI RefSeq. However, 
when a member of this gene family (G241) was expressed 
in E. coli, we did not observe any increase in MIC. Closer 
analysis of the regions surrounding the identified gene in the 
25 strains of Acinetobacter baumannii revealed an insertion 
sequence (ISAba6) located in direct connection to the gene in 
one of the strains, suggesting that the gene could potentially 
be mobile [72].
Analysis of the phylogenetic tree in the neighbourhood 
around the previously known mobile tetracycline resistance 
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genes provided further insights into their recent evolutionary 
history. Phylogenetic analysis of the ribosomal protection 
genes showed, for example, that otr(A) was most closely 
related to genes found in various Actinobacteria, including 
many species from the genus Streptomyces (Fig. 4). The chro-
mosomal gene closest to otr(A) was located in the species 
Amycolatopsis sp., but the evolutionary distance to otr(A) was 
still substantial. The otr(A) gene has previously been found 
in Streptomyces spp. and Mycobacterium spp. [4]. and our 
results suggest, in accordance with the literature, that this 
gene has likely been mobilized from an unknown Actino-
bacteria species [4, 73]. Indeed, the majority of the clinically 
used antibiotics are produced by Actinobacteria, and several 
classes of resistance genes are hypothesized to originate 
from this phylum [74, 75]. The other known mobile ribo-
somal protection genes were located in a single clade where 
only two of the novel gene families were found in isolated 
species, both Firmicutes (NF98, Lachnospiraceae spp., and 
NF60, Clostridium spp.). Ribosomal protection genes were 
in general common in Bacteroidetes, but no species in this 
phylum contained a chromosomal non- mobile gene that was 
close evolutionary to any mobile ribosomal protection gene. 
Therefore, it is plausible that the mobile ribosomal protection 
genes originated elsewhere – based on the current evidence 
most likely Firmicutes – and were horizontally transferred to 
Bacteroidetes. It should be pointed out that a wide range of 
species from both phyla are naturally occurring in animal and 
human microbiomes, suggesting that there is both ecological 
connectivity and tetracycline selection pressure that may 
enable horizontal gene transfer.
The phylogenetic tree of the efflux pump genes (Fig. 5) was 
heavily dominated by genes from Proteobacteria and all of 
the known mobile efflux pumps had their closest relative 
within this phylum. This strongly suggests that mobile efflux 
pump genes were mobilized from Proteobacteria. However, 
the evolutionary distances were large and no mobile efflux 
pump gene with high sequence identity to a non- mobile 
efflux pump gene was found, suggesting that the origin – or 
origins – are species with yet uncharacterized genomes. Note, 
however, that one of the genes closest related to any previously 
known mobile efflux pump gene was located in O. anthropi 
(Betaproteobacteria), an opportunistic pathogen known to 
thrive in a large variety of habitats [76]. Furthermore, the 
O. anthropi gene showed high resistance against tetracycline 
when expressed in E. coli.
The enzymatic resistance genes had few matches in the 
genomic data, and based on the available information, it is 
difficult to assess their origin with certainty. We did, however, 
identify a new family related to tet(X) (NF20), which, like the 
tetX1 and the tet(X) family, was found in Bacteroidetes species 
(Fig. 3). Furthermore, the tetX1 genes were always found 
together with a copy of tet(X), except for a reconstructed tetX1 
gene from the pig microbiome. Interestingly, this was not the 
case for the genes in NF20, which appeared both in Niabella 
ginsenosidivorans and in a metagenome from a wastewater 
treatment plant. We were not able to identify any elements 
associated with known mechanisms for horizontal gene 
transfer, suggesting that these genes may be chromosomal. 
Considering the high degree of mobility among tet(X)- like 
genes in Bacteroidetes [12], it is hard to assess if this is the 
origin of the gene or if the genes were horizontally transferred 
to this part of the taxonomic tree.
The method, fARGene, used in this study applies probabilistic 
gene models in the form of hidden Markov models to identify 
novel resistance genes [22]. The models have been optimized 
to accurately discriminate between homologues with and 
without a resistance phenotype to keep the number of false 
positives low [19]. Nevertheless, all genes identified in this 
study are predictions and, therefore, it is necessary to experi-
mentally verify if they can induce resistance phenotypes and, 
if that is the case, in what hosts they are functional. In this 
study, we selected 17 of the predicted genes for verification in 
E. coli and among those 7 were found to be functional. Note, 
however, that even some well- known tetracycline resistance 
genes that are functional in other species do not induce a 
significant resistance phenotype in E. coli. In particular, 
ribosomal protection genes, which are rare in Proteobacteria, 
confer only low levels of resistance when expressed in E. coli 
[4]. Indeed, several ribosomal protection genes showed only 
a small increase in MIC, but the functionality of two of these 
genes could be verified with the considerably more sensitive 
growth assay. Therefore, it cannot be excluded that other 
genes which did not result in an increased MIC in E. coli may 
be functional and, potentially, be much more potent in other 
hosts. In addition, experimental verification was performed 
based on the exact predicted protein sequences without codon 
optimization; therefore, an impaired expression may explain 
the lack of function in E. coli. Furthermore, we cannot exclude 
that some of the predicted genes may have other molecules as 
their natural substrate and, thus, demonstrate a lower efficacy 
for tetracyclines. Also, we cannot disregard the possibility that 
some of the predicted genes may be false positives; thus, they 
should be considered putative until further experimental 
verification has been made.
Conclusion
Screening of more than 12 Tb of genomic and metagenomic 
data was used to identify 195 families of tetracycline resist-
ance genes, of which 164 families were novel predictions and 
previously uncharacterized. Phylogenetic analysis suggested 
that mobile tetracycline resistance genes were mobilized 
from different parts of the taxonomical tree, where ribosomal 
protection genes originated from Firmicutes and Actinobac-
teria, while efflux pump genes originated from proteobacte-
rial species. Enzymatic genes were scarce; therefore, their 
evolutionary origin remains unclear. Several of the novel 
mobile genes showed patterns of horizontal transfer between 
bacterial phyla. This study expands the known tetracycline 
resistome, and describes the reservoir of resistant determi-
nants maintained by environmental and commensal bacteria. 
If mobilized and transferred to pathogens, these genes could 
reduce the efficacy of existing and future tetracycline anti-
biotics and thereby pose a significant threat to our ability to 
treat bacterial infections.
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